Logiscreen

Tandem Diabetes Care Inc

$19.34
Market Cap 1.32B
ROE -68.3%
Gross Margin 55.3%
Debt/Equity 5.5
Current Ratio 3.6
Revenue QoQ 5.5%
EPS QoQ -0.8%
F-Score 0

About

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-14.06
vs median 33.61
P/B
10.04
vs median 2.16
ROE
-0.68
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics